Maden C, Hopkins S G, Smyser M, Lafferty W E
HIV/AIDS Epidemiology Unit, Seattle-King County Department of Public Health, WA 98104.
J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1157-61.
Survival analysis was performed for AIDS cases diagnosed in Washington state from 1982 through 1989 and reported through October 31, 1991. No difference in survival time among diagnosis years 1987, 1988, and 1989 (p = 0.29) was found. Since September 1987, survival time was longest for cases with human immunodeficiency virus (HIV) wasting syndrome and HIV encephalopathy. Adjusted risk for death was significantly lower for these cases relative to all other cases (relative risk, 0.5; 95% confidence interval, 0.4-0.6). Explanations for the absence of continuing increase in survival time between 1987 and 1989 include changes in the frequency and timing of anti-HIV therapy. Longer survival time among cases diagnosed with HIV wasting or HIV encephalopathy is likely due to diagnosis earlier in the course of HIV disease. These results emphasize how changes over time in the definition of AIDS and evolving therapeutic standards may affect assessment of survival time when using surveillance data.
对1982年至1989年在华盛顿州诊断出并截至1991年10月31日报告的艾滋病病例进行了生存分析。未发现1987年、1988年和1989年诊断年份之间的生存时间存在差异(p = 0.29)。自1987年9月以来,患有人类免疫缺陷病毒(HIV)消瘦综合征和HIV脑病的病例生存时间最长。相对于所有其他病例,这些病例的调整后死亡风险显著更低(相对风险,0.5;95%置信区间,0.4 - 0.6)。1987年至1989年生存时间没有持续增加的原因包括抗HIV治疗的频率和时机变化。被诊断患有HIV消瘦或HIV脑病的病例生存时间更长可能是由于在HIV疾病进程中更早被诊断。这些结果强调了随着时间推移艾滋病定义的变化以及不断发展的治疗标准在使用监测数据时可能如何影响生存时间的评估。